The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1): study protocol and review of literature

Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition which results in a mortality of up to 33%. Up to 40% of infants treated with nitric oxide (iNO) either have a transient response or fail to demonstrate an improvement in oxygenation. Milrinone, a selective phosp...

Descripción completa

Detalles Bibliográficos
Autores principales: EL-Khuffash, Afif, McNamara, Patrick J., Breatnach, Colm, Bussmann, Neidin, Smith, Aisling, Feeney, Oliver, Tully, Elizabeth, Griffin, Joanna, de Boode, Willem P., Cleary, Brian, Franklin, Orla, Dempsey, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276183/
https://www.ncbi.nlm.nih.gov/pubmed/30524749
http://dx.doi.org/10.1186/s40748-018-0093-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276183/
https://www.ncbi.nlm.nih.gov/pubmed/30524749
http://dx.doi.org/10.1186/s40748-018-0093-1

Ejemplares similares